In a 55‑year‑old woman presenting with dry cough, exertional dyspnea, wheezing, and generalized weakness for one day (SpO₂ 94% on room air, blood pressure 140/90 mmHg, pulse 98 bpm, temperature 37 °C), with normal vesicular breath sounds and a normal chest X‑ray, and a history of allergic cough while taking cetirizine, escitalopram, clonazepam, azithromycin, and dexamethasone syrup for three days without symptom resolution, how should I approach her management?

Approach to Management

This patient requires immediate escalation of asthma therapy with nebulized bronchodilators and systemic corticosteroids, as she meets criteria for acute asthma exacerbation despite her current inadequate treatment regimen.

Immediate Assessment & Red Flag Evaluation

First, objectively assess severity using peak expiratory flow (PEF) measurement—this is critical as severity is often underestimated without objective measures 1. Her current presentation suggests moderate-to-severe asthma:

• Concerning features present:

  • Exertional dyspnea (100 meters)
  • Wheezing
  • SpO₂ 94% (borderline hypoxemia)
  • Pulse 98 bpm (approaching tachycardia threshold of >110)
  • Failed 3-day treatment course

• Check for severe asthma criteria 1:

  • Can she complete sentences in one breath?
  • Respiratory rate >25/min?
  • Heart rate >110 bpm?
  • PEF <50% predicted?

• Life-threatening features to exclude 1:

  • Silent chest, cyanosis, feeble respiratory effort
  • Bradycardia, hypotension
  • Exhaustion, confusion, coma
  • PEF <33% predicted

Critical Problems with Current Management

The current medication regimen is fundamentally flawed:

1. Azithromycin is inappropriate 1—antibiotics should only be given if bacterial infection is present. Normal chest X-ray and absence of fever make bacterial infection unlikely.

2. Dexamethasone syrup dosing is unclear and likely inadequate—she needs high-dose systemic corticosteroids (prednisolone 30-60 mg orally or hydrocortisone 200 mg IV) 1.

3. No bronchodilator therapy—she requires high-dose inhaled β-agonists immediately.

4. Cetirizine alone is insufficient for asthma control, though it may help allergic components 2, 3.

Immediate Treatment Protocol

If PEF >50% predicted (Moderate Exacerbation):

Administer immediately 1:

• Nebulized salbutamol 5 mg (or terbutaline 10 mg) with oxygen if available
  • Alternative: 2 puffs via large-volume spacer, repeat 10-20 times
• Prednisolone 30-60 mg orally (or IV hydrocortisone 200 mg if vomiting)
• Oxygen 40-60% to maintain SpO₂ >92%

Monitor response at 15-30 minutes 1:

• Repeat PEF measurement
• If PEF improves to >75% predicted: continue treatment, step up maintenance therapy
• If PEF remains 50-75%: repeat nebulized β-agonist, continue prednisolone
• If any severe features persist: arrange hospital admission

If PEF <50% predicted (Severe Exacerbation):

Immediate treatment 1:

• Nebulized salbutamol 5 mg with oxygen
• Prednisolone 30-60 mg or IV hydrocortisone 200 mg
• Add ipratropium 0.5 mg to nebulizer
• Strongly consider hospital admission

Hospital Admission Criteria 1:

Admit if:

• Any life-threatening features
• PEF <33% after initial treatment
• Features of severe asthma persist after initial treatment
• Lower threshold for admission because:
  • Presentation in afternoon/evening (higher risk)
  • Recent symptom worsening
  • Concern about patient's ability to assess severity
  • Social circumstances

Ongoing Management

Discontinue Inappropriate Medications:

• Stop azithromycin immediately 1—no bacterial infection evident
• Continue cetirizine 10 mg for allergic component
• Caution: Escitalopram and clonazepam are appropriate for her psychiatric conditions but monitor for sedation 4, 5—sedation is contraindicated in acute asthma 1

Step-Up Long-Term Control 6, 7:

Once acute exacerbation resolves:

1. Initiate or optimize inhaled corticosteroids (ICS)—first-line for persistent asthma 8, 6
2. Consider adding leukotriene receptor antagonist (montelukast) if incomplete response 6
3. Add long-acting β-agonist (LABA) only in combination with ICS, never as monotherapy 8

Follow-Up Protocol 1:

• Review within 24-48 hours after acute treatment
• Monitor symptoms and PEF with peak flow diary
• Provide written self-management plan
• Assess inhaler technique
• Modify treatment according to chronic asthma guidelines

Critical Pitfalls to Avoid

1. Do not rely on clinical assessment alone—measure PEF objectively 1
2. Do not continue antibiotics—no indication present 1
3. Do not use sedatives—contraindicated in acute asthma 1
4. Do not delay systemic corticosteroids—essential for preventing deterioration 1, 8
5. Do not discharge without objective improvement—PEF should be >75% predicted with <25% diurnal variability 1
6. Do not assume normal chest X-ray excludes asthma—chest radiography is primarily to exclude complications (pneumothorax, pneumonia) 1

Additional Considerations

Blood pressure 140/90 mmHg warrants follow-up but should not delay asthma treatment. The combination of azithromycin and cetirizine may prolong QTc interval 9, providing another reason to discontinue azithromycin.

Specialist referral indicated if 1:

• Diagnostic uncertainty
• Poor response to optimized treatment
• Recurrent severe exacerbations
• Difficulty achieving control